The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.
This morning in London: The FTSE 100 is currently up 70 points at 6562.
FX and commodities: GBP/USD is down 14 pips at $1.6375, EUR/USD is down six pips at $1.3677 and USD/JPY is down 32 pips at ¥103.96. Brent crude is down 11 cents at $109.19 and gold is trading at $1215, down $3.20.
Stocks: AstraZeneca is close to completing the control of its diabetes joint venture with Bristol-Myers Squibb, expected to cost in the region of $3 billion. Keller Group has posted a trading update stating it envisages full-year figures will be in line with market expectations. Both G4S and Serco will find out their fate after a government-wide probe of their contracts. It is likely that the remunerations to be re-paid could total £50 million.
The day ahead: US FOMC members yesterday voted to start tapering, so the long wait is finally over. A reduction of the monthly $85 billion debt-purchasing scheme down to $75 billion is set to begin. However, there will need to be further improvements in US economic data before any additional cuts can be considered. .
All figures correct at 8.30am. All times London time.